ID

26089

Beschreibung

Carboplatin+Nab-paclitaxel, Plus Trastuzumab (HER2+) or Bevacizumab (HER2-) in the Neoadjuvant Setting; ODM derived from: https://clinicaltrials.gov/show/NCT00618657

Link

https://clinicaltrials.gov/show/NCT00618657

Stichworte

Versionen (1)
  1. 09.10.17 09.10.17 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

9. Oktober 2017

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Breast Cancer NCT00618657

Englisch

Eligibility Breast Cancer NCT00618657

1 Formulare  
Criteria
Beschreibung

Criteria

physical examination, and scans needed for tumor assessment must be performed within 90 days prior to registration
Beschreibung

Neoplasm Assessment Physical Examination | Neoplasm Assessment Scanning

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0027651
UMLS CUI [1,2]
C1516048
UMLS CUI [1,3]
C0031809
UMLS CUI [2,1]
C0027651
UMLS CUI [2,2]
C1516048
UMLS CUI [2,3]
C0441633
patients with the clinical diagnosis of congestive heart failure or angina pectoris are not eligible
Beschreibung

Congestive heart failure Exclusion | Angina Pectoris Exclusion

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0018802
UMLS CUI [1,2]
C2828389
UMLS CUI [2,1]
C0002962
UMLS CUI [2,2]
C2828389
serum creatinine within normal limits within 90 days prior to registration
Beschreibung

Creatinine measurement, serum

Datentyp

boolean

Alias
UMLS CUI [1]
C0201976
bilirubin within normal limits within 90 days prior to registration
Beschreibung

Serum total bilirubin measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C1278039
serum glutamic oxaloacetic transaminase (sgot) or serum glutamate pyruvate transaminase (sgpt) =< 2 x the institutional upper limit of normal within 90 days prior to registration
Beschreibung

Aspartate aminotransferase measurement | Alanine aminotransferase measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C0201899
UMLS CUI [2]
C0201836
absolute neutrophil count (anc) of >= 1,500/microliters within 90 days prior to registration
Beschreibung

Absolute neutrophil count

Datentyp

boolean

Alias
UMLS CUI [1]
C0948762
platelet count of >= 100,000/microliters within 90 days prior to registration
Beschreibung

Platelet Count measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C0032181
patients must have a performance status of 0-2 by zubrod criteria
Beschreibung

Zubrod Performance Status

Datentyp

boolean

Alias
UMLS CUI [1]
C3714786
pregnant or nursing women may not participate; women of reproductive potential may not participate unless they have agreed to use an effective contraceptive method; pregnancy test required for women of childbearing potential
Beschreibung

Pregnancy Exclusion | Breast Feeding Exclusion | Childbearing Potential Contraceptive methods | Childbearing Potential Pregnancy Test

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0032961
UMLS CUI [1,2]
C2828389
UMLS CUI [2,1]
C0006147
UMLS CUI [2,2]
C2828389
UMLS CUI [3,1]
C3831118
UMLS CUI [3,2]
C0700589
UMLS CUI [4,1]
C3831118
UMLS CUI [4,2]
C0032976
in calculating days of tests and measurements, the day a test or measurement is done is considered day 0; therefore, if a test is done on a monday, the monday four weeks later would be considered day 28; this allows for efficient patient scheduling without exceeding the guidelines; if day 28 or 42 falls on a weekend or holiday, the limit may be extended to the next working day
Beschreibung

Tests | Measurement | Schedules, Patient

Datentyp

boolean

Alias
UMLS CUI [1]
C0392366
UMLS CUI [2]
C0242485
UMLS CUI [3]
C0030703
all patients must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines
Beschreibung

Informed Consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Breast Cancer NCT00618657

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Neoplasm Assessment Physical Examination | Neoplasm Assessment Scanning
Item
physical examination, and scans needed for tumor assessment must be performed within 90 days prior to registration
boolean
C0027651 (UMLS CUI [1,1])
C1516048 (UMLS CUI [1,2])
C0031809 (UMLS CUI [1,3])
C0027651 (UMLS CUI [2,1])
C1516048 (UMLS CUI [2,2])
C0441633 (UMLS CUI [2,3])
Congestive heart failure Exclusion | Angina Pectoris Exclusion
Item
patients with the clinical diagnosis of congestive heart failure or angina pectoris are not eligible
boolean
C0018802 (UMLS CUI [1,1])
C2828389 (UMLS CUI [1,2])
C0002962 (UMLS CUI [2,1])
C2828389 (UMLS CUI [2,2])
Creatinine measurement, serum
Item
serum creatinine within normal limits within 90 days prior to registration
boolean
C0201976 (UMLS CUI [1])
Serum total bilirubin measurement
Item
bilirubin within normal limits within 90 days prior to registration
boolean
C1278039 (UMLS CUI [1])
Aspartate aminotransferase measurement | Alanine aminotransferase measurement
Item
serum glutamic oxaloacetic transaminase (sgot) or serum glutamate pyruvate transaminase (sgpt) =< 2 x the institutional upper limit of normal within 90 days prior to registration
boolean
C0201899 (UMLS CUI [1])
C0201836 (UMLS CUI [2])
Absolute neutrophil count
Item
absolute neutrophil count (anc) of >= 1,500/microliters within 90 days prior to registration
boolean
C0948762 (UMLS CUI [1])
Platelet Count measurement
Item
platelet count of >= 100,000/microliters within 90 days prior to registration
boolean
C0032181 (UMLS CUI [1])
Zubrod Performance Status
Item
patients must have a performance status of 0-2 by zubrod criteria
boolean
C3714786 (UMLS CUI [1])
Pregnancy Exclusion | Breast Feeding Exclusion | Childbearing Potential Contraceptive methods | Childbearing Potential Pregnancy Test
Item
pregnant or nursing women may not participate; women of reproductive potential may not participate unless they have agreed to use an effective contraceptive method; pregnancy test required for women of childbearing potential
boolean
C0032961 (UMLS CUI [1,1])
C2828389 (UMLS CUI [1,2])
C0006147 (UMLS CUI [2,1])
C2828389 (UMLS CUI [2,2])
C3831118 (UMLS CUI [3,1])
C0700589 (UMLS CUI [3,2])
C3831118 (UMLS CUI [4,1])
C0032976 (UMLS CUI [4,2])
Tests | Measurement | Schedules, Patient
Item
in calculating days of tests and measurements, the day a test or measurement is done is considered day 0; therefore, if a test is done on a monday, the monday four weeks later would be considered day 28; this allows for efficient patient scheduling without exceeding the guidelines; if day 28 or 42 falls on a weekend or holiday, the limit may be extended to the next working day
boolean
C0392366 (UMLS CUI [1])
C0242485 (UMLS CUI [2])
C0030703 (UMLS CUI [3])
Informed Consent
Item
all patients must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines
boolean
C0021430 (UMLS CUI [1])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video